Parameters | Expression of SKA3 | p-value | |
---|---|---|---|
Low | High | ||
Age (years) | 0.3598 | ||
 ≥ 50 | 2 (5%) | 15 (37.5%) |  |
 < 50 | 4 (10%) | 19 (47.5%) |  |
TNM stage | 0.999 | ||
 I + II | 6 (15%) | 32 (80%) |  |
 III + IV | 0 (0%) | 2 (5%) |  |
Clinical stage | 0.999 | ||
 I + II | 5 (12.5%) | 29 (72.5%) |  |
 III + IV | 1 (2.5%) | 5 (12.5%) |  |